Gabelli & Co Investment Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-351,075	Closed	-$40.6M	–	311
2023 Q3	$40.6M	Buy	351,075 +22,600	+7%	+$2.61M	6.61%	2
2023 Q2	$33.8M	Buy	328,475 +22,875	+7%	+$2.35M	5.65%	1
2023 Q1	$33.4M	Buy	305,600 +157,900	+107%	+$17.2M	6.4%	1
2022 Q4	$16.8M	Buy	+147,700	New	+$16.8M	3.58%	6